Trail Ridge Investment Advisors’s Elevance Health ELV Stock Holding History

Trail Ridge Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-636	Closed	-$264K	–	104
2024 Q3	$264K	Hold	636	–	–	0.13%	98
2024 Q2	$345K	Hold	636	–	–	0.18%	85
2024 Q1	$330K	Hold	636	–	–	0.19%	83
2023 Q4	$300K	Sell	636 -35	-5%	-$16.2K	0.18%	89
2023 Q3	$292K	Sell	671 -2,665	-80%	-$1.21M	0.2%	84
2023 Q2	$1.48M	Hold	3,336	–	–	0.91%	34
2023 Q1	$1.53M	Hold	3,336	–	–	1%	31
2022 Q4	$1.71M	Hold	3,336	–	–	1.18%	26
2022 Q3	$1.64M	Hold	3,336	–	–	1.08%	28
2022 Q2	$1.61M	Hold	3,336	–	–	1.09%	24
2022 Q1	$1.64M	Hold	3,336	–	–	1.01%	27
2021 Q4	$1.55M	Buy	+3,336	New	+$1.4M	0.93%	31

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Trail Ridge Investment Advisors's ELV Position: Q4 2024 in Review

Trail Ridge Investment Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 636 shares — an estimated $264K sold.

Trail Ridge Investment Advisors first reported a position in ELV in Q4 2021 and held it in 12 quarters. The position peaked at $1.71M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Trail Ridge Investment Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Trail Ridge Investment Advisors sold 636 Elevance Health shares in Q4 2024, an estimated $264K.
Trail Ridge Investment Advisors first reported a position in Elevance Health in Q4 2021 and held it in 12 quarters.
Trail Ridge Investment Advisors's Elevance Health position peaked at $1.71M in Q4 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Trail Ridge Investment Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.